tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PLRX Stock Latest News

Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
Press ReleasesPliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
20d ago
PLRX
Pliant Therapeutics announces accelerated bexotegrast development plan
PremiumThe Fly
Pliant Therapeutics announces accelerated bexotegrast development plan
1M ago
PLRX
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
PremiumPress Releases
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
1M ago
PLRX
Pliant Therapeutics price target lowered to $50 from $53 at RBC Capital
PremiumThe Fly
Pliant Therapeutics price target lowered to $50 from $53 at RBC Capital
2M ago
PLRX
3 Best Stocks to Buy Now, 2/28/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 2/28/2024, According to Top Analysts
2M ago
EVLV
MLTX
Pliant Therapeutics reports Q4 EPS (69c), consensus (81c)
PremiumThe FlyPliant Therapeutics reports Q4 EPS (69c), consensus (81c)
2M ago
PLRX
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
PremiumPress Releases
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
2M ago
PLRX
Pliant Therapeutics price target lowered to $43 from $48 at Canaccord
PremiumThe Fly
Pliant Therapeutics price target lowered to $43 from $48 at Canaccord
2M ago
PLRX
Pliant Therapeutics price target lowered to $47 from $49 at Oppenheimer
PremiumThe Fly
Pliant Therapeutics price target lowered to $47 from $49 at Oppenheimer
2M ago
PLRX
Pliant Therapeutics Achieves Success in Liver Disease Trial
PremiumCompany Announcements
Pliant Therapeutics Achieves Success in Liver Disease Trial
2M ago
8K
PLRX
3 Best Stocks to Buy Now, 2/6/2024, According to Top Analysts 
PremiumStock Analysis & Ideas
3 Best Stocks to Buy Now, 2/6/2024, According to Top Analysts 
2M ago
WEX
GENI
Pliant Therapeutics price target lowered to $48 from $52 at H.C. Wainwright
PremiumThe Fly
Pliant Therapeutics price target lowered to $48 from $52 at H.C. Wainwright
2M ago
PLRX
Pliant Therapeutics announces data from INTEGRIS-PSC Phase 2a trial
PremiumThe FlyPliant Therapeutics announces data from INTEGRIS-PSC Phase 2a trial
2M ago
PLRX
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
PremiumPress Releases
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
2M ago
PLRX
The biotech stocks to own in 2024, according to Piper Sandler
PremiumThe Fly
The biotech stocks to own in 2024, according to Piper Sandler
3M ago
ALT
ALGS
Pliant Therapeutics initiated with an Overweight at Wells Fargo
PremiumThe Fly
Pliant Therapeutics initiated with an Overweight at Wells Fargo
4M ago
PLRX
Pliant Therapeutics initiated with an Overweight at Wells Fargo
PremiumThe Fly
Pliant Therapeutics initiated with an Overweight at Wells Fargo
4M ago
PLRX
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
5M ago
AKRO
ARWR
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
5M ago
AKRO
ARWR
Pliant Therapeutics Presentations at The Liver Meeting® 2023 Highlight Bexotegrast, an Inhibitor of αvß6 and αvß1 Integrins, in Primary Sclerosing Cholangitis
PremiumPress ReleasesPliant Therapeutics Presentations at The Liver Meeting® 2023 Highlight Bexotegrast, an Inhibitor of αvß6 and αvß1 Integrins, in Primary Sclerosing Cholangitis
5M ago
PLRX
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
5M ago
AKRO
ARWR
Pliant Therapeutics price target lowered to $49 from $52 at Oppenheimer
PremiumThe Fly
Pliant Therapeutics price target lowered to $49 from $52 at Oppenheimer
5M ago
PLRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >